Response to Hamid et al., "Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy"

Cabello, JuanJuanCabelloDavid K. UrionRodrigo Salinas2025-08-252025-08-252024-09-2710.1016/j.pediatrneurol.2024.09.019https://cris-uv.scimago.es/handle/123456789/5082WOS:001344248400001enacceso restringidoResponse to Hamid et al., "Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy"letter to the editor